DNA damage signaling is activated during cancer progression in human colorectal carcinoma

Kazuhito Oka, Toshiki Tanaka, Tadahiko Enoki, Koichi Yoshimura, Mako Ohshima, Masayuki Kubo, Tomoyuki Murakami, Toshikazu Gondou, Yoshihide Minami, Yoshihiro Takemoto, Eijirou Harada, Takaaki Tsushimi, Tao Sheng Li, Frank Traganos, Zbigniew Darzynkiewicz, Kimikazu Hamano

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: Recent studies have shown that the DNA damage response (DDR) is activated in precancerous lesions, suggesting that neoplastic cells may avoid apoptosis by impairing the DDR which acts as a barrier against tumor progression. To define the role of the DDR pathway in human colorectal carcinoma, we investigated the level of phosphorylated proteins of the DDR pathway. Results: Immunostaining for pATM, γH2AX and pChk2 revealed that all were significantly expressed during tumor progression in advanced carcinoma (vs. normal tissue for pATM [p <0.05]; vs. normal and adenoma for γH2AX [p <0.05]; and vs. normal tissue for pChk2 [p <0.05]. Western blot analysis of γH2AX and pChk2 revealed that their level increased gradually during tumor progression and was maximal in advanced carcinoma (vs. normal tissue; p <0.05). No apoptotic cells were found in any tissue sample. Experimental design: Colorectal tissue samples were obtained at the time of surgery, from 55 patients at two hospitals. The tissues were classified into four groups according to pathology: normal mucosa, adenoma, early carcinoma and advanced carcinoma. We evaluated phosphorylated ataxia telangiectasia mutated (pATM), phosphorylated H2AX (γH2AX) and Chk2 (pChk2) protein levels by immunohistochemistry and western blot analysis. We also evaluated apoptosis by the TUNEL assay. Conclusions: The DDR pathway was activated during cancer progression, but no apoptosis was detected, even among the cells with activated DDR. It is likely that activation of DDR was induced by stress signaling as a consequence of oxidative, replication and mechanical stresses occurring during growth and expansion of the colorectal cancer.

Original languageEnglish
Pages (from-to)246-252
Number of pages7
JournalCancer Biology and Therapy
Volume9
Issue number3
DOIs
Publication statusPublished - Feb 1 2010
Externally publishedYes

Fingerprint

DNA Damage
Colorectal Neoplasms
Ataxia Telangiectasia
Neoplasms
Carcinoma
Apoptosis
Adenoma
Western Blotting
Mechanical Stress
In Situ Nick-End Labeling
Mucous Membrane
Proteins
Oxidative Stress
Research Design
Immunohistochemistry
Pathology
Growth

Keywords

  • Apoptosis
  • ATM
  • Cancer progression
  • Chk2
  • Colorectal carcinoma
  • DNA damage response
  • H2AX

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Oka, K., Tanaka, T., Enoki, T., Yoshimura, K., Ohshima, M., Kubo, M., ... Hamano, K. (2010). DNA damage signaling is activated during cancer progression in human colorectal carcinoma. Cancer Biology and Therapy, 9(3), 246-252. https://doi.org/10.4161/cbt.9.3.10751

DNA damage signaling is activated during cancer progression in human colorectal carcinoma. / Oka, Kazuhito; Tanaka, Toshiki; Enoki, Tadahiko; Yoshimura, Koichi; Ohshima, Mako; Kubo, Masayuki; Murakami, Tomoyuki; Gondou, Toshikazu; Minami, Yoshihide; Takemoto, Yoshihiro; Harada, Eijirou; Tsushimi, Takaaki; Li, Tao Sheng; Traganos, Frank; Darzynkiewicz, Zbigniew; Hamano, Kimikazu.

In: Cancer Biology and Therapy, Vol. 9, No. 3, 01.02.2010, p. 246-252.

Research output: Contribution to journalArticle

Oka, K, Tanaka, T, Enoki, T, Yoshimura, K, Ohshima, M, Kubo, M, Murakami, T, Gondou, T, Minami, Y, Takemoto, Y, Harada, E, Tsushimi, T, Li, TS, Traganos, F, Darzynkiewicz, Z & Hamano, K 2010, 'DNA damage signaling is activated during cancer progression in human colorectal carcinoma', Cancer Biology and Therapy, vol. 9, no. 3, pp. 246-252. https://doi.org/10.4161/cbt.9.3.10751
Oka, Kazuhito ; Tanaka, Toshiki ; Enoki, Tadahiko ; Yoshimura, Koichi ; Ohshima, Mako ; Kubo, Masayuki ; Murakami, Tomoyuki ; Gondou, Toshikazu ; Minami, Yoshihide ; Takemoto, Yoshihiro ; Harada, Eijirou ; Tsushimi, Takaaki ; Li, Tao Sheng ; Traganos, Frank ; Darzynkiewicz, Zbigniew ; Hamano, Kimikazu. / DNA damage signaling is activated during cancer progression in human colorectal carcinoma. In: Cancer Biology and Therapy. 2010 ; Vol. 9, No. 3. pp. 246-252.
@article{acef1561f60b4a88aa63211c8d136c32,
title = "DNA damage signaling is activated during cancer progression in human colorectal carcinoma",
abstract = "Purpose: Recent studies have shown that the DNA damage response (DDR) is activated in precancerous lesions, suggesting that neoplastic cells may avoid apoptosis by impairing the DDR which acts as a barrier against tumor progression. To define the role of the DDR pathway in human colorectal carcinoma, we investigated the level of phosphorylated proteins of the DDR pathway. Results: Immunostaining for pATM, γH2AX and pChk2 revealed that all were significantly expressed during tumor progression in advanced carcinoma (vs. normal tissue for pATM [p <0.05]; vs. normal and adenoma for γH2AX [p <0.05]; and vs. normal tissue for pChk2 [p <0.05]. Western blot analysis of γH2AX and pChk2 revealed that their level increased gradually during tumor progression and was maximal in advanced carcinoma (vs. normal tissue; p <0.05). No apoptotic cells were found in any tissue sample. Experimental design: Colorectal tissue samples were obtained at the time of surgery, from 55 patients at two hospitals. The tissues were classified into four groups according to pathology: normal mucosa, adenoma, early carcinoma and advanced carcinoma. We evaluated phosphorylated ataxia telangiectasia mutated (pATM), phosphorylated H2AX (γH2AX) and Chk2 (pChk2) protein levels by immunohistochemistry and western blot analysis. We also evaluated apoptosis by the TUNEL assay. Conclusions: The DDR pathway was activated during cancer progression, but no apoptosis was detected, even among the cells with activated DDR. It is likely that activation of DDR was induced by stress signaling as a consequence of oxidative, replication and mechanical stresses occurring during growth and expansion of the colorectal cancer.",
keywords = "Apoptosis, ATM, Cancer progression, Chk2, Colorectal carcinoma, DNA damage response, H2AX",
author = "Kazuhito Oka and Toshiki Tanaka and Tadahiko Enoki and Koichi Yoshimura and Mako Ohshima and Masayuki Kubo and Tomoyuki Murakami and Toshikazu Gondou and Yoshihide Minami and Yoshihiro Takemoto and Eijirou Harada and Takaaki Tsushimi and Li, {Tao Sheng} and Frank Traganos and Zbigniew Darzynkiewicz and Kimikazu Hamano",
year = "2010",
month = "2",
day = "1",
doi = "10.4161/cbt.9.3.10751",
language = "English",
volume = "9",
pages = "246--252",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "3",

}

TY - JOUR

T1 - DNA damage signaling is activated during cancer progression in human colorectal carcinoma

AU - Oka, Kazuhito

AU - Tanaka, Toshiki

AU - Enoki, Tadahiko

AU - Yoshimura, Koichi

AU - Ohshima, Mako

AU - Kubo, Masayuki

AU - Murakami, Tomoyuki

AU - Gondou, Toshikazu

AU - Minami, Yoshihide

AU - Takemoto, Yoshihiro

AU - Harada, Eijirou

AU - Tsushimi, Takaaki

AU - Li, Tao Sheng

AU - Traganos, Frank

AU - Darzynkiewicz, Zbigniew

AU - Hamano, Kimikazu

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Purpose: Recent studies have shown that the DNA damage response (DDR) is activated in precancerous lesions, suggesting that neoplastic cells may avoid apoptosis by impairing the DDR which acts as a barrier against tumor progression. To define the role of the DDR pathway in human colorectal carcinoma, we investigated the level of phosphorylated proteins of the DDR pathway. Results: Immunostaining for pATM, γH2AX and pChk2 revealed that all were significantly expressed during tumor progression in advanced carcinoma (vs. normal tissue for pATM [p <0.05]; vs. normal and adenoma for γH2AX [p <0.05]; and vs. normal tissue for pChk2 [p <0.05]. Western blot analysis of γH2AX and pChk2 revealed that their level increased gradually during tumor progression and was maximal in advanced carcinoma (vs. normal tissue; p <0.05). No apoptotic cells were found in any tissue sample. Experimental design: Colorectal tissue samples were obtained at the time of surgery, from 55 patients at two hospitals. The tissues were classified into four groups according to pathology: normal mucosa, adenoma, early carcinoma and advanced carcinoma. We evaluated phosphorylated ataxia telangiectasia mutated (pATM), phosphorylated H2AX (γH2AX) and Chk2 (pChk2) protein levels by immunohistochemistry and western blot analysis. We also evaluated apoptosis by the TUNEL assay. Conclusions: The DDR pathway was activated during cancer progression, but no apoptosis was detected, even among the cells with activated DDR. It is likely that activation of DDR was induced by stress signaling as a consequence of oxidative, replication and mechanical stresses occurring during growth and expansion of the colorectal cancer.

AB - Purpose: Recent studies have shown that the DNA damage response (DDR) is activated in precancerous lesions, suggesting that neoplastic cells may avoid apoptosis by impairing the DDR which acts as a barrier against tumor progression. To define the role of the DDR pathway in human colorectal carcinoma, we investigated the level of phosphorylated proteins of the DDR pathway. Results: Immunostaining for pATM, γH2AX and pChk2 revealed that all were significantly expressed during tumor progression in advanced carcinoma (vs. normal tissue for pATM [p <0.05]; vs. normal and adenoma for γH2AX [p <0.05]; and vs. normal tissue for pChk2 [p <0.05]. Western blot analysis of γH2AX and pChk2 revealed that their level increased gradually during tumor progression and was maximal in advanced carcinoma (vs. normal tissue; p <0.05). No apoptotic cells were found in any tissue sample. Experimental design: Colorectal tissue samples were obtained at the time of surgery, from 55 patients at two hospitals. The tissues were classified into four groups according to pathology: normal mucosa, adenoma, early carcinoma and advanced carcinoma. We evaluated phosphorylated ataxia telangiectasia mutated (pATM), phosphorylated H2AX (γH2AX) and Chk2 (pChk2) protein levels by immunohistochemistry and western blot analysis. We also evaluated apoptosis by the TUNEL assay. Conclusions: The DDR pathway was activated during cancer progression, but no apoptosis was detected, even among the cells with activated DDR. It is likely that activation of DDR was induced by stress signaling as a consequence of oxidative, replication and mechanical stresses occurring during growth and expansion of the colorectal cancer.

KW - Apoptosis

KW - ATM

KW - Cancer progression

KW - Chk2

KW - Colorectal carcinoma

KW - DNA damage response

KW - H2AX

UR - http://www.scopus.com/inward/record.url?scp=77953577964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953577964&partnerID=8YFLogxK

U2 - 10.4161/cbt.9.3.10751

DO - 10.4161/cbt.9.3.10751

M3 - Article

C2 - 20023412

AN - SCOPUS:77953577964

VL - 9

SP - 246

EP - 252

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 3

ER -